Inc. NERV,This biopharmaceutical company develops and commercialises various products designed to treat central nervous system diseases, including schizophrenia, insomnia, and Parkinson’s disease.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Minerva Neurosciences, Inc. - NERV - Share chat | 0 | 119 | 1 February 2024 | |
Neurocrine Biosciences Inc NBIX | 0 | 375 | 10 November 2020 | |
Prothena Corporation plc PRTA | 0 | 431 | 10 November 2020 | |
Supernus Pharm SUPN | 0 | 242 | 10 November 2020 | |
Neumora Therapeutics Inc - NMRA - Share chat | 1 | 158 | 3 November 2023 |